Fort Sheridan Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Fort Sheridan Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$823K	Buy	4,329 +46	+1%	+$7.91K	0.09%	137
2026 Q1	$723K	Buy	4,283 +150	+4%	+$25.6K	0.09%	143
2025 Q4	$698K	Hold	4,133	–	–	0.09%	133
2025 Q3	$597K	Hold	4,133	–	–	0.08%	147
2025 Q2	$523K	Buy	4,133 +298	+8%	+$36.6K	0.07%	152
2025 Q1	$491K	Hold	3,835	–	–	0.07%	150
2024 Q4	$507K	Sell	3,835 -279	-7%	-$39.2K	0.07%	152
2024 Q3	$599K	Buy	4,114 +188	+5%	+$27.2K	0.09%	137
2024 Q2	$539K	Buy	3,926 +49	+1%	+$6.54K	0.09%	136
2024 Q1	$532K	Buy	3,877 +8	+0.2%	+$1.09K	0.1%	126
2023 Q4	$526K	Hold	3,869	–	–	0.1%	120
2023 Q3	$473K	Buy	3,869 +2,250	+139%	+$286K	0.11%	119
2023 Q2	$206K	Buy	+1,619	New	+$210K	0.05%	187

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Fort Sheridan Advisors's IBB Position: Q2 2026 in Review

Fort Sheridan Advisors increased its iShares Biotechnology ETF (IBB) stake by 1.1% in Q2 2026, buying an estimated $7.91K and bringing the position to 4,329 shares worth $823K. The position accounts for 0.09% of the portfolio, ranked #137.

Fort Sheridan Advisors first reported a position in IBB in Q2 2023 and has held it in 13 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Fort Sheridan Advisors held 4,329 shares of iShares Biotechnology ETF worth $823K as of Q2 2026.
Fort Sheridan Advisors bought 46 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.91K.
iShares Biotechnology ETF made up 0.09% of Fort Sheridan Advisors's portfolio in Q2 2026, its #137 holding.
Fort Sheridan Advisors first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 13 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.